GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (OTCPK:ENTBF) » Definitions » Days Sales Outstanding

Entheon Biomedical (Entheon Biomedical) Days Sales Outstanding : 0.00 (As of Feb. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Entheon Biomedical Days Sales Outstanding?

Entheon Biomedical's average Accounts Receivable for the three months ended in Feb. 2024 was $0.00 Mil. Entheon Biomedical's Revenue for the three months ended in Feb. 2024 was $0.00 Mil.

The historical rank and industry rank for Entheon Biomedical's Days Sales Outstanding or its related term are showing as below:

ENTBF's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 72.545
* Ranked among companies with meaningful Days Sales Outstanding only.

Entheon Biomedical's Days Sales Outstanding stayed the same from Feb. 2023 (0.00) to Feb. 2024 (0.00).

Entheon Biomedical Days Sales Outstanding Historical Data

The historical data trend for Entheon Biomedical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Days Sales Outstanding Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23
Days Sales Outstanding
Get a 7-Day Free Trial - - - - -

Entheon Biomedical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Entheon Biomedical's Days Sales Outstanding

For the Biotechnology subindustry, Entheon Biomedical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Days Sales Outstanding falls into.


Entheon Biomedical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Entheon Biomedical's Days Sales Outstanding for the fiscal year that ended in Nov. 2023 is calculated as

Days Sales Outstanding (A: Nov. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Nov. 2022 ) + Accounts Receivable (A: Nov. 2023 )) / count ) / Revenue (A: Nov. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0.182*365
=0 / 0.182*365
=0.00

Entheon Biomedical's Days Sales Outstanding for the quarter that ended in Feb. 2024 is calculated as:

Days Sales Outstanding (Q: Feb. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Nov. 2023 ) + Accounts Receivable (A: Feb. 2024 )) / count ) / Revenue (A: Feb. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical  (OTCPK:ENTBF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Entheon Biomedical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Entheon Biomedical (Entheon Biomedical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (OTCPK:ENTBF) » Definitions » Days Sales Outstanding
Comparable Companies
XCNQ:MYND XCNQ:ABRT XCNQ:WESA.X TSXV:BTI XCNQ:HAVN TSXV:IBO XCNQ:GTTX TSXV:APC.H XCNQ:MOOD XCNQ:NSHS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
1XU1:Germany ENBI:Canada
Address
999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Website
https://www.entheonbiomedical.com
Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.